Under normal conditions, aqueous humor is continuously produced and drained from the eye to maintain healthy pressure levels. When goniodysgenesis is present, the drainage pathway becomes partially or severely compromised. As a result, fluid may not exit the eye efficiently, leading to increased intraocular pressure. Persistent elevation of eye pressure can damage the optic nerve and retina, causing pain, vision impairment, and potentially irreversible blindness.
The severity of clinical signs can vary among affected dogs. Some dogs with goniodysgenesis may never develop glaucoma, while others may experience sudden or progressive increases in eye pressure. Early signs can include excessive tearing, redness of the eye, sensitivity to light, squinting, or mild vision changes. As glaucoma develops, symptoms may become more severe and can include eye enlargement, corneal cloudiness, significant discomfort, vision loss, and eventual blindness if left untreated. Glaucoma is considered a veterinary emergency, and early detection is critical for preserving vision and reducing pain.
The GGD DNA Health Test is designed to identify genetic variants associated with Severe Goniodysgenesis and increased glaucoma risk. Testing is simple and non-invasive, typically requiring either a cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to determine whether the dog carries the mutation linked to the condition. Since the test examines inherited DNA, it can be performed at any age, including in puppies before symptoms develop.
Results are generally reported in one of three categories:
- Clear (Normal): The dog does not carry the tested GGD mutation and is unlikely to pass it to offspring.
- Carrier: The dog carries one copy of the mutation and may not show clinical signs but can pass the mutation to future generations.
- Affected/At Risk: The dog carries the disease-associated mutation and has an increased risk of developing severe goniodysgenesis and glaucoma during its lifetime.
Genetic testing for GGD provides valuable information for breeders, veterinarians, and dog owners. Breeders can use test results to make informed mating decisions that help reduce the prevalence of the condition while maintaining genetic diversity within the breed. Careful breeding management can significantly decrease the number of dogs born with a heightened risk of glaucoma.
For dog owners, understanding a dog's genetic status allows for proactive eye health monitoring. Dogs identified as at risk can benefit from regular ophthalmic examinations, gonioscopy assessments, and intraocular pressure measurements. Early veterinary surveillance increases the likelihood of detecting changes before significant vision loss occurs.
The Severe Goniodysgenesis & Glaucoma Risk (GGD) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine eye health, and helps reduce the impact of inherited glaucoma-related disorders. Through early detection and informed breeding decisions, breeders and owners can contribute to healthier dogs and improved long-term visual welfare.
